Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|9|3|184-190

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.9, Iss.3, 2011-09, pp. : 184-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

High hopes for Herceptin in inflammatory breast cancer

By  

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1147-1156

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Bcl-2 in CLL

By  

Current Medicinal Chemistry, Vol. 19, Iss. 30, 2012-10 ,pp. : 5109-5115

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Nitro-Heterocycles Sugar and Indoles Candidates as Lead Structures Targeting HepG2 and A549 Cancer Cell Lines

By  

Current Bioactive Compounds, Vol. 14, Iss. 4, 2018-12 ,pp. : 434-444

Bentham Science Publishers

Access to resources Recommend Favorite